Correction to Lancet Respir Med 2019; 7: 46-59

No authors listed

Published Erratum

No authors listed. Lancet Respir Med. 2019 Jan.

. 2019 Jan;7(1):e1.

doi: 10.1016/S2213-2600(18)30518-6.

No abstract available

Erratum for

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial.
Busse WW, Bleecker ER, FitzGerald JM, Ferguson GT, Barker P, Sproule S, Olsson RF, Martin UJ, Goldman M; BORA study investigators. Busse WW, et al. Lancet Respir Med. 2019 Jan;7(1):46-59. doi: 10.1016/S2213-2600(18)30406-5. Epub 2018 Nov 8. Lancet Respir Med. 2019. PMID: 30416083 Clinical Trial.